These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8327469

  • 1. Thalidomide inhibits the replication of human immunodeficiency virus type 1.
    Makonkawkeyoon S, Limson-Pobre RN, Moreira AL, Schauf V, Kaplan G.
    Proc Natl Acad Sci U S A; 1993 Jul 01; 90(13):5974-8. PubMed ID: 8327469
    [Abstract] [Full Text] [Related]

  • 2. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
    La Maestra L, Zaninoni A, Marriott JB, Lazzarin A, Dalgleish AG, Barcellini W.
    Clin Exp Immunol; 2000 Jan 01; 119(1):123-9. PubMed ID: 10606973
    [Abstract] [Full Text] [Related]

  • 3. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV, Saget BM, Angel JB, Wang MZ, Wang A, Dinarello CA, Skolnik PR.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr 15; 11(5):430-7. PubMed ID: 8605587
    [Abstract] [Full Text] [Related]

  • 4. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
    Angel JB, Saget BM, Walsh SP, Greten TF, Dinarello CA, Skolnik PR, Endres S.
    AIDS; 1995 Oct 15; 9(10):1137-44. PubMed ID: 8519449
    [Abstract] [Full Text] [Related]

  • 5. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells.
    Fazely F, Dezube BJ, Allen-Ryan J, Pardee AB, Ruprecht RM.
    Blood; 1991 Apr 15; 77(8):1653-6. PubMed ID: 1707692
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB, Saget BM, Wang MZ, Wang A, Dinarello CA, Skolnik PR.
    J Interferon Cytokine Res; 1995 Jun 15; 15(6):575-84. PubMed ID: 7553227
    [Abstract] [Full Text] [Related]

  • 7. Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone.
    Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I.
    Immunol Lett; 1999 Jun 01; 68(2-3):325-32. PubMed ID: 10424439
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.
    Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS.
    Proc Natl Acad Sci U S A; 1990 Jan 01; 87(2):782-5. PubMed ID: 2300561
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B.
    Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I.
    Int Immunopharmacol; 2001 Jan 01; 1(1):49-61. PubMed ID: 11367517
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA.
    Yang JY, Schwartz A, Henderson EE.
    AIDS Res Hum Retroviruses; 1993 Aug 01; 9(8):747-54. PubMed ID: 7692906
    [Abstract] [Full Text] [Related]

  • 11. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
    Okamoto M, Ono M, Baba M.
    AIDS Res Hum Retroviruses; 1998 Sep 20; 14(14):1239-45. PubMed ID: 9764907
    [Abstract] [Full Text] [Related]

  • 12. 9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone.
    Moulton S, Pantazis P, Epstein JS, Sadaie MR.
    AIDS Res Hum Retroviruses; 1998 Jan 01; 14(1):39-49. PubMed ID: 9453250
    [Abstract] [Full Text] [Related]

  • 13. Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis.
    Bekker LG, Haslett P, Maartens G, Steyn L, Kaplan G.
    J Infect Dis; 2000 Mar 01; 181(3):954-65. PubMed ID: 10720518
    [Abstract] [Full Text] [Related]

  • 14. Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.
    Ho WZ, Zhu XH, Song L, Lee HR, Cutilli JR, Douglas SD.
    AIDS Res Hum Retroviruses; 1995 Apr 01; 11(4):451-9. PubMed ID: 7632461
    [Abstract] [Full Text] [Related]

  • 15. A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
    Weissman D, Poli G, Bousseau A, Fauci AS.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2537-41. PubMed ID: 7681601
    [Abstract] [Full Text] [Related]

  • 16. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
    Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G.
    J Exp Med; 1993 Jun 01; 177(6):1675-80. PubMed ID: 8496685
    [Abstract] [Full Text] [Related]

  • 17. Phenylarsine oxide inhibits ex vivo HIV-1 expression.
    Arbault S, Edeas M, Legrand-Poels S, Sojic N, Amatore C, Piette J, Best-Belpomme M, Lindenbaum A, Vuillaume M.
    Biomed Pharmacother; 1997 Jun 01; 51(10):430-8. PubMed ID: 9863501
    [Abstract] [Full Text] [Related]

  • 18. Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro.
    Moreira AL, Corral LG, Ye W, Johnson B, Stirling D, Muller GW, Freedman VH, Kaplan G.
    AIDS Res Hum Retroviruses; 1997 Jul 01; 13(10):857-63. PubMed ID: 9197379
    [Abstract] [Full Text] [Related]

  • 19. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
    Simon G, Moog C, Obert G.
    Chem Biol Interact; 1994 Jun 01; 91(2-3):111-21. PubMed ID: 7514959
    [Abstract] [Full Text] [Related]

  • 20. Pertussis toxin inhibits induction of human immunodeficiency virus type 1 in infected monocytes.
    Chowdhury IH, Koyanagi Y, Hazeki O, Ui M, Yamamoto N.
    Virology; 1994 Sep 01; 203(2):378-83. PubMed ID: 8053161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.